149 related articles for article (PubMed ID: 29362820)
1. Subtherapeutic valproic acid plasma concentrations under concomitant dipyrone therapy in an epilepsy patient-a case report.
Morath B; Green K; Zaradzki M; Heid J; Karck M; Hoppe-Tichy T
Eur J Clin Pharmacol; 2018 May; 74(5):675-677. PubMed ID: 29362820
[No Abstract] [Full Text] [Related]
2. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
Avakian GN; Oleĭnikova OM; Lagutin IuV; Khromykh EA; Bogomazova MA; Delger AB; Avakian GG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
[TBL] [Abstract][Full Text] [Related]
3. Serum valproate levels with oral contraceptive use.
Herzog AG; Farina EL; Blum AS
Epilepsia; 2005 Jun; 46(6):970-1. PubMed ID: 15946343
[No Abstract] [Full Text] [Related]
4. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
5. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
Gidal BE; Pitterle ME; Spencer NW; Maly MM
J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
8. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
[TBL] [Abstract][Full Text] [Related]
9. [Valproic acid serum through concentrations estimated from 12 hours post-dose concentrations in patients treated with Depakine® Crono].
Lampón N; Tutor JC
Farm Hosp; 2013; 37(1):79-80. PubMed ID: 23461508
[No Abstract] [Full Text] [Related]
10. Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine.
Droulers A; Bodak N; Oudjhani M; Lefevre des Noettes V; Bodak A
J Clin Psychopharmacol; 1997 Apr; 17(2):139-40. PubMed ID: 10950492
[No Abstract] [Full Text] [Related]
11. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
13. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
Fudio S; Carcas A; Piñana E; Ortega R
J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
[TBL] [Abstract][Full Text] [Related]
14. Seizure worsening caused by decreased serum valproate during meropenem therapy.
Santucci M; Parmeggiani A; Riva R
J Child Neurol; 2005 May; 20(5):456-7. PubMed ID: 15968935
[TBL] [Abstract][Full Text] [Related]
15. Predicted plasma valproic acid concentrations in patients missing and replacing a full daily dose of extended-release divalproex sodium.
Dutta S; Reed RC
Am J Health Syst Pharm; 2006 May; 63(10):904-6. PubMed ID: 16675645
[No Abstract] [Full Text] [Related]
16. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
Yoon HY; Ahn MH; Yee J; Lee N; Han JM; Gwak HS
Eur J Clin Pharmacol; 2020 Aug; 76(8):1053-1058. PubMed ID: 32385545
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
El Desoky E; Kandil MR; Afifi AH; Mostafa OA
Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
[TBL] [Abstract][Full Text] [Related]
18. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
19. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
[TBL] [Abstract][Full Text] [Related]
20. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
Gu J; Huang Y
Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
